Erste gemeinsame europäische Leitlinie zur pharmakologischen MS-Therapie
Crossref DOI link: https://doi.org/10.1007/s15005-018-2567-0
Published Online: 2018-04-18
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Text and Data Mining valid from 2018-04-01
Article History
First Online: 18 April 2018